CR

Chandrashekhar Ramachandran Iyer

Active Director Director DIN 07173310
DIN 07173310 First appointment May 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since May 2015
Shareholding value •••• Premium profile

About Chandrashekhar Ramachandran Iyer

Data last updated:

Chandrashekhar Ramachandran Iyer is a Director at Cipla Health Limited (since 2019) and Director at Jay Precision Pharmaceuticals Private Limited (since 2019). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1,380 Cr; the largest is Cipla Health Limited at ₹1,229 Cr (FY 2025). Earlier, Chandrashekhar Ramachandran Iyer was a Director at Cipla Pharma And Life Sciences Limited (2015–2019) and Director at Goldencross Pharma Limited (2015–2019) and 3 more.

DIN 07173310
Primary Designation Director
Industry Pharma
First Appointment 01 May 2015
Oldest Company Age 14 yrs
Largest company Cipla Health Limited · ₹1,229 Cr (FY 2025)
Combined revenue ₹1,380 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cipla Health Limited U24100MH2015PLC267880
Director27 Mar 20192015₹1,229 Cr (FY 2025)Active
Director10 Sep 20192012₹152 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 May 20152008₹1,598 Cr (FY 2025)Active
Goldencross Pharma Limited U24239MH2000PLC123766
Director01 May 20152000₹188 Cr (FY 2025)Active
Meditab Specialities Limited U23240MH1996PLC104442
Director01 May 20151996₹40.03 Cr (FY 2025)Active
Director18 Mar 20161992₹444 Cr (FY 2025)Active
Designated Partner15 Nov 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cipla Health Limited
Jay Precision Pharmaceuticals Private Limited
Chandrashekhar Iyer & Co Llp
Cipla Pharma And Life Sciences Limited
Premium access

Shareholding and investment profile for Chandrashekhar Ramachandran Iyer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrashekhar Ramachandran Iyer

Chandrashekhar Ramachandran Iyer currently holds 2 directorships: Cipla Health Limited (Director, since 27 Mar 2019, revenue ₹1,229 Cr (FY 2025)); Jay Precision Pharmaceuticals Private Limited (Director, since 10 Sep 2019, revenue ₹152 Cr (FY 2025)).

Chandrashekhar Ramachandran Iyer was first appointed on 01 May 2015 as Director at Cipla Pharma And Life Sciences Limited. The most recent appointment on record is 10 Sep 2019 at Jay Precision Pharmaceuticals Private Limited.

The 2 current companies of Chandrashekhar Ramachandran Iyer that report revenue have a combined latest revenue of ₹1,380 Cr: Cipla Health Limited ₹1,229 Cr (FY 2025); Jay Precision Pharmaceuticals Private Limited ₹152 Cr (FY 2025).

Chandrashekhar Ramachandran Iyer held 5 earlier board appointments: Cipla Pharma And Life Sciences Limited (Director, 01 May 2015 to 02 Jan 2019); Goldencross Pharma Limited (Director, 01 May 2015 to 03 Jan 2019); Meditab Specialities Limited (Director, 01 May 2015 to 03 Jan 2019); Medispray Laboratories Private Limited (Director, 18 Mar 2016 to 07 Jan 2019); Chandrashekhar Iyer & Co Llp (Designated Partner, from 15 Nov 2016).

The current boards of Chandrashekhar Ramachandran Iyer's companies include Achin Gupta (Cipla Health Limited), Amrita Nautiyal (Cipla Health Limited), Geena Malhotra (Cipla Health Limited), Shivam Puri (Cipla Health Limited), Shivam Puri (Cipla Health Limited), Siddharth Rajesh Jain (Cipla Health Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available